5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with Gastrointestinal Stromal Neoplasm in 1 studies
5-nitro-2-(3-phenylpropylamino)benzoic acid: structure given in first source; chloride channel antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simon, S | 1 |
| Grabellus, F | 1 |
| Ferrera, L | 1 |
| Galietta, L | 1 |
| Schwindenhammer, B | 1 |
| Mühlenberg, T | 1 |
| Taeger, G | 1 |
| Eilers, G | 1 |
| Treckmann, J | 1 |
| Breitenbuecher, F | 1 |
| Schuler, M | 1 |
| Taguchi, T | 1 |
| Fletcher, JA | 1 |
| Bauer, S | 1 |
1 other study available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and Gastrointestinal Stromal Neoplasm
| Article | Year |
|---|---|
DOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors.
Topics: Animals; Anoctamin-1; Antineoplastic Agents; Benzamides; Blotting, Western; Cell Line, Tumor; Cell P | 2013 |